Sarah Stapleton

641 total citations
12 papers, 482 citations indexed

About

Sarah Stapleton is a scholar working on Public Health, Environmental and Occupational Health, Cancer Research and Molecular Biology. According to data from OpenAlex, Sarah Stapleton has authored 12 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Sarah Stapleton's work include Ethics in Clinical Research (5 papers), Biomedical Ethics and Regulation (2 papers) and Dementia and Cognitive Impairment Research (2 papers). Sarah Stapleton is often cited by papers focused on Ethics in Clinical Research (5 papers), Biomedical Ethics and Regulation (2 papers) and Dementia and Cognitive Impairment Research (2 papers). Sarah Stapleton collaborates with scholars based in United Kingdom, Australia and Canada. Sarah Stapleton's co-authors include Ian Judson, Udai Banerji, Michelle Scurr, Yasmin J. Asad, Michael I. Walton, Sunil R. Lakhani, Alison Maloney, Florence I. Raynaud, Anne O’Donnell and Laura K. Simmons and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Sarah Stapleton

10 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Stapleton United Kingdom	5	329	79	74	51	50	12	482
Srinivas Annavarapu United States	11	575 1.7×	88 1.1×	124 1.7×	47 0.9×	20 0.4×	27	854
Melvin Gaskins United States	6	162 0.5×	26 0.3×	125 1.7×	133 2.6×	19 0.4×	8	435
Mike Walton United Kingdom	6	388 1.2×	83 1.1×	77 1.0×	8 0.2×	69 1.4×	15	486
Travis P. Schrank United States	15	588 1.8×	32 0.4×	80 1.1×	10 0.2×	32 0.6×	35	795
Katarzyna Śmietana United States	8	267 0.8×	52 0.7×	74 1.0×	44 0.9×	59 1.2×	12	543
Sudhakar Jakkaraj United States	7	208 0.6×	9 0.1×	100 1.4×	54 1.1×	77 1.5×	13	396
Yinchun Ji China	18	450 1.4×	61 0.8×	171 2.3×	11 0.2×	39 0.8×	51	802
Karen Rowan United States	13	201 0.6×	29 0.4×	88 1.2×	15 0.3×	34 0.7×	29	430
Angela Hu United States	11	258 0.8×	79 1.0×	139 1.9×	31 0.6×	21 0.4×	23	470
Shulin Han United States	9	316 1.0×	126 1.6×	41 0.6×	8 0.2×	45 0.9×	13	442

Countries citing papers authored by Sarah Stapleton

Since Specialization

Citations

This map shows the geographic impact of Sarah Stapleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Stapleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Stapleton more than expected).

Fields of papers citing papers by Sarah Stapleton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Stapleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Stapleton. The network helps show where Sarah Stapleton may publish in the future.

Co-authorship network of co-authors of Sarah Stapleton

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Stapleton. A scholar is included among the top collaborators of Sarah Stapleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Stapleton. Sarah Stapleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Hill, Meredith, Sarah Stapleton, Phuong Thao Nguyen, et al.. (2024). The potential regulation of the miR-17–92a cluster by miR-21. The International Journal of Biochemistry & Cell Biology. 178. 106705–106705.

Hainsworth, Emma, Sarah Stapleton, Geraldine O’Gara, et al.. (2024). 28P A mixed methods longitudinal process evaluation and implementation study of ctDNA use to guide adjuvant chemotherapy decision-making in patients with colorectal cancer: A sub-study of the ongoing UK wide interventional TRACC part C trial. Annals of Oncology. 35. S14–S14.

Stapleton, Sarah, Anne‐Sophie Darlington, Johann S. de Bono, & Theresa Wiseman. (2022). What is the impact of targeted therapies given within phase I trials on the cognitive function of patients with advanced cancer: a mixed-methods exploratory study conducted in an early clinical trials unit. BMJ Open. 12(11). e050590–e050590. 1 indexed citations

Pal, Abhijit, Sarah Stapleton, Christina Yap, et al.. (2021). Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT). BMJ Open. 11(9). e049217–e049217. 1 indexed citations

Stapleton, Sarah, Anne‐Sophie Darlington, Anna Minchom, et al.. (2021). Assessing cognitive toxicity in early phase trials ‐ What are we missing?. Psycho-Oncology. 31(3). 405–415. 1 indexed citations

Pal, Abhijit, Sarah Stapleton, Julia Lai‐Kwon, et al.. (2020). 1886P Quantifying quality of informed consent (IC) in patients enrolled in phase I (ph I) oncology clinical trials with a validated instrument (QuIC Parts A, B) in a large United Kingdom phase I trials unit. Annals of Oncology. 31. S1072–S1072. 1 indexed citations

Pal, Abhijit, Sarah Stapleton, & Juanita Lopez. (2019). Filling the gaps in informed consent for advanced cancer patients considering phase I oncology trials: An in-depth qualitative study of key stakeholders at a large United Kingdom phase I unit. Annals of Oncology. 30. v744–v744. 1 indexed citations

Dolly, Saoirse, Eleftheria Kalaitzaki, M. Puglisi, et al.. (2016). A study of motivations and expectations of patients seen in phase 1 oncology clinics. Cancer. 122(22). 3501–3508. 26 indexed citations

Wiseman, Theresa, Grace Lucas, Sarah Stapleton, et al.. (2015). Insights into the experiences of patients with cancer in London: framework analysis of free-text data from the National Cancer Patient Experience Survey 2012/2013 from the two London Integrated Cancer Systems. BMJ Open. 5(10). e007792–e007792. 28 indexed citations

10.

Stapleton, Sarah & Natalie Pattison. (2014). The lived experience of men with advanced cancer in relation to their perceptions of masculinity: a qualitative phenomenological study. Journal of Clinical Nursing. 24(7-8). 1069–1078. 19 indexed citations

11.

Karavasilis, Vasilios, Laurence Digue, Tobias Arkenau, et al.. (2008). Identification of factors limiting patient recruitment into phase I trials: A study from the Royal Marsden Hospital. European Journal of Cancer. 44(7). 978–982. 27 indexed citations

12.

Banerji, Udai, Anne O’Donnell, Michelle Scurr, et al.. (2005). Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies. Journal of Clinical Oncology. 23(18). 4152–4161. 377 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact